<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25651363</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>05</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1523-1755</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>88</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2015</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Kidney international</Title>
                <ISOAbbreviation>Kidney Int.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.</ArticleTitle>
            <Pagination>
                <MedlinePgn>404-11</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ki.2014.382</ELocationID>
            <Abstract>
                <AbstractText>Hyperkalemia contributes to significant mortality and limits the use of cardioprotective and renoprotective renin-angiotensin-aldosterone blockers. Current therapies are poorly tolerated and not always effective. Here we conducted a phase 2 randomized, double-blind, placebo-controlled dose-escalation study to assess safety and efficacy of ZS-9. This oral selective cation exchanger that preferentially entraps potassium in the gastrointestinal tract was given to patients with stable Stage 3 chronic kidney disease and hyperkalemia (5.0 to 6.0 mEq/l) during a 2-day period. Of 90 eligible patients with mean baseline serum potassium of 5.1 mEq/l, 30 were randomized to placebo, 12-0.3 g, 24-3 g, or 24 to 10 g of ZS-9 three times daily for 2 days with regular meals. None withdrew and ZS-9 dose-dependently reduced serum potassium. The primary efficacy end point (rate of serum potassium decline in the first 48 h) was met with significance in the 3- and 10-g cohorts. From baseline, mean serum potassium was significantly decreased by 0.92±0.52 mEq/l at 38 h. Urinary potassium excretion significantly decreased with 10-g ZS-9 as compared to placebo at day 2 (+15.8 +/- 21.8 vs. +8.9 +/- 22.9 mEq per 24h) from placebo at day 2. In this short-term study, no serious adverse events were reported; only mild constipation in the 3-g dose group was possibly related to treatment. Thus, ZS-9 was well-tolerated in patients with stable chronic kidney disease and hyperkalemia leading to a rapid, sustained reduction in serum potassium. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ash</LastName>
                    <ForeName>Stephen R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nephrology, Indiana University Health Arnett, Lafayette, Indiana, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Bhupinder</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>1] Apex Research of Riverside, Riverside, California, USA [2] ZS Pharma, Coppell, Texas, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lavin</LastName>
                    <ForeName>Philip T</ForeName>
                    <Initials>PT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Boston Biostatistics Research Foundation, Framingham, Massachusetts, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stavros</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>ZS Pharma, Coppell, Texas, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasmussen</LastName>
                    <ForeName>Henrik S</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>ZS Pharma, Coppell, Texas, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>02</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Kidney Int</MedlineTA>
            <NlmUniqueID>0323470</NlmUniqueID>
            <ISSNLinking>0085-2538</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017920">Antiporters</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017640">Silicates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000597310">ZS-9 compound</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>RWP5GA015D</RegistryNumber>
                <NameOfSubstance UI="D011188">Potassium</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017920" MajorTopicYN="N">Antiporters</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003248" MajorTopicYN="N">Constipation</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006947" MajorTopicYN="N">Hyperkalemia</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011188" MajorTopicYN="N">Potassium</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017640" MajorTopicYN="N">Silicates</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>2</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>5</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25651363</ArticleId>
            <ArticleId IdType="pii">S2157-1716(15)32161-4</ArticleId>
            <ArticleId IdType="doi">10.1038/ki.2014.382</ArticleId>
            <ArticleId IdType="pmc">PMC4526769</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Soc Nephrol. 1998 Oct;9(10):1924-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9773794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1961 Jan 19;264:111-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13700297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1961 Jan 19;264:115-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13747532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2005;(2):CD003235</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15846652</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2009 Jun 22;169(12):1156-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19546417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Dial. 2009 Nov-Dec;22(6):615-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20017831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2010 May;21(5):733-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20167700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrology (Carlton). 2010 Jun;15(4):406-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20609091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ASAIO J. 2010 Nov-Dec;56(6):550-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21245802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Med. 2011 Mar;6(3):136-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21387549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2012 Jan 11;307(2):157-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22235086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Cardiol. 2012 May 15;109(10):1510-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22342847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1966 Jan 22;1(7430):167-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4164887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chronic Dis. 1966 May;19(5):573-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5338082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1977 Nov;12(5):354-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 1988 Oct;85(4):507-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3052050</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1992 Feb;41(2):369-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1552710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Miner Electrolyte Metab. 1991;17(5):297-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1668124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 1996 Oct;28(4):508-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8840939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2012 Aug;7(8):1272-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22626960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 2013 Mar;126(3):264.e9-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23321430</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2013 May;8(5):714-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23393105</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2012 Sep;60(3):409-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22683337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2012 Nov;38(11):1834-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22806439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2013 Jan;61(1 Suppl 1):A7, e1-476</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23253259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Nephrol Hypertens. 2013 Mar;22(2):193-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23380803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Esp Enferm Dig. 2013 Apr;105(4):232-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23859454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med Sci. 2014 Feb;347(2):93-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23255245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2014 Mar;85(3):529-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24107852</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>